BOULDER, Colo., Dec. 11, 2025 /PRNewswire/ — Enliven Therapeutics, Inc. (“Enliven”), (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that on December 11, 2025, Enliven granted an…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
GREENWOOD VILLAGE, Colo., Sept. 27, 2022 /PRNewswire/ — RAIsonance, Inc., today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its AudibleHealth Dx […]
New facility doubles urgent care capacity, expands services under one roof, and anchors Kaiser Permanente’s largest brick‑and‑mortar investment in Colorado in 15 years DENVER, Jan. 13, 2026 /PRNewswire/ — Kaiser Permanente plans to open its […]
TULSA, Okla.–(BUSINESS WIRE)–Four startups headquartered in Colorado, Florida and Texas have been selected as winners of the 2026 Rose Rock Bridge Showcase. Austere Environmental, BiaTech, BigMachine AI and Intellicess will receive a share of $400,000 […]
Copyright © 2026 Biotech Networks
